Work

Heterodimeric JAK-STAT Activation As a Mechanism of Persistence to JAK2 Inhibitor Therapy

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.122.122

Authors: Neha Bhagwat, Priya Koppikar, Outi Kilpivaara, Taghi Manshouri, Mazhar Adli, Ann Mullally, Omar Abdel-Wahab, Laura Leung, Abby Weinstein, Sachie Marubayashi, Aviva Goel, Mithat Gonen, Zeev Estrov, Benjamin L. Ebert, Gabriela Chiosis, Bradley Bernstein, Srdan Verstovsek, Ross L Levine

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2545659482

FWCI: 0.434

Cites:

Cited by: 19

Related to: 10